Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7714056

Concept 2018-04-01 to
2018-12-31
As at
2018-12-31
2018-10-01 to
2018-12-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
154,621,000 JPY
354,410,000 JPY
246,634,000 JPY
Ordinary profit (loss)
-1,272,609,000 JPY
-1,573,292,000 JPY
-1,172,418,000 JPY
Net assets
5,504,339,000 JPY
6,950,570,000 JPY
4,231,955,000 JPY
Total assets
5,690,725,000 JPY
7,235,902,000 JPY
4,471,402,000 JPY
Basic earnings (loss) per share
-35.09
-10.79
-41.25
-31.52
-13.06
Diluted earnings per share
Equity-to-asset ratio
0.955 xbrli:pure
0.953 xbrli:pure
0.934 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.